Toshifumi Yamaguchi

机构：Osaka Medical and Pharmaceutical University, Osaka University of Pharmaceutical Sciences · ORCID：0000-0003-1399-1918

发表论文 138 篇 · 总被引 408 次 · h-index 10

代表论文

Adjuvant mFOLFOXFIRI after curative-intent resection of oligometastatic colorectal cancer: Phase II FANTASTIC trial. (2026 · Journal of Clinical Oncology · 被引 2)
A multicenter phase II trial of encorafenib, binimetinib, and cetuximab for early relapsed stage II/III BRAF V600E -mutated colorectal cancer: TRESBIEN trial (OGSG 2101). (2026 · Journal of Clinical Oncology · 被引 1)
Copy Number-Based Oncogene Dominance May Suggest ERBB2 Dependence and Trastuzumab Response in HER2-Positive Gastric Cancer (2026 · Targeted Oncology · 被引 1)
Neoadjuvant docetaxel, oxaliplatin, and S-1 therapy for patients with large type 3 or type 4 gastric cancer: final outcomes of a multicenter, phase II study (OGSG 1902) (2026 · Gastric Cancer · 被引 1)
A multicenter phase II trial of ramucirumab plus irinotecan for early recurrence of gastric cancer during or after adjuvant chemotherapy with docetaxel plus S-1 therapy: the RAMIEL trial (OGSG1901) (2026 · Gastric Cancer)
Prognostic impact of circulating tumor RAS and BRAF mutation dynamics in patients with metastatic colorectal cancer (2026 · iScience)